Cart
sales@molnova.com
Antineoplaston A10(b)
CAS No. 91531-30-5
Antineoplaston A10(b)( NSC-648539 )
Catalog No. M20619 CAS No. 91531-30-5
Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma lymphoma astrocytoma and breast cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 2MG | 37 | In Stock |
|
| 5MG | 62 | In Stock |
|
| 10MG | 105 | In Stock |
|
| 25MG | 204 | In Stock |
|
| 50MG | 305 | In Stock |
|
| 100MG | 440 | In Stock |
|
| 200MG | 616 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAntineoplaston A10(b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionAntineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma lymphoma astrocytoma and breast cancer.
-
DescriptionAntineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma lymphoma astrocytoma and breast cancer.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC-648539
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research AreaCancer
-
IndicationAnaplastic astrocytoma; Glioma
Chemical Information
-
CAS Number91531-30-5
-
Formula Weight246.26
-
Molecular FormulaC13H14N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (1015.19 mM)
-
SMILESO=C(Cc1ccccc1)N[C@H]1CCC(=O)NC1=O
-
Chemical NameN-[(3S)-26-dioxopiperidin-3-yl]-2-phenylacetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qu X J Cui S X Tian Z et al. Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10[J]. Anticancer Research 2007 27(4B):2427.
molnova catalog
related products
-
J-104871
J-104871 (UNII-6137X5QNJF) is a novel farnesyltransferase (FTase) inhibitor that competitively blocks Ras farnesylation in vivo, inhibits Ras processing in activated H-ras-transformed NIH3T3 cells, and suppresses tumor growth in nude mice transplanted with activated H-ras-transformed NIH3T3 cells.
-
AMG-510
Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state.
-
CID-1067700
CID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases（Rab7 with a Ki of 13 nM).
